| Name | (2S)-2-[[(2S)-1-(2-carboxyethylamino)-1-oxo-3-phenylpropan-2-yl]amino]-3-phenylpropanoic acid |
|---|---|
| Synonyms | (N-(1-Carboxy-2-phenyl)ethyl)phenylalanyl-B-alanine |
| Description | SCH 32615 is an enkephalinase (the enzymes responsible for the degradation of endogenous enkephalins) inhibitor. SCH 32615 can enhance surgery- and pregnancy-induced analgesia in mice[1][2]. |
|---|---|
| Related Catalog | |
| Target |
enkephalinase[1] |
| In Vitro | SCH 32615 blocks the degradation of Met5-enkephalin by isolated enkephalinase, with the Ki of 19.5 nM[3]. |
| In Vivo | SCH 32615 (150 mg/kg; s.c.) enhances surgery activated endogenous analgesia in mice[1]. |
| References |
| Density | 1.267g/cm3 |
|---|---|
| Boiling Point | 683ºC at 760 mmHg |
| Molecular Formula | C21H24N2O5 |
| Molecular Weight | 384.42600 |
| Flash Point | 366.9ºC |
| Exact Mass | 384.16900 |
| PSA | 119.22000 |
| LogP | 2.70530 |
| Index of Refraction | 1.594 |